Electrochemotherapy is a novel treatment which consists of a combination of
a chemotherapeutic agent and pulsed electric fields. This relatively new t
reatment modality relies on the physical effects of locally applied electri
c fields to temporarily destabilize cell membranes in the presence of a dru
g to allow increased uptake of the agent into the cytosol. Electrochemother
apy has been used effectively in preclinical and clinical studies. The ther
apy was shown to be effective regardless of histologic type of tumor includ
ing head and neck squamous cell carcinoma, melanoma, basal cell carcinoma,
adenocarcinoma and Kaposi's sarcoma. Objective response rates ranging from
72 percent to 100 percent have been reported from these trials. These respo
nses were obtained with minimal adverse side effects. A review of the clini
cal data for this novel drug delivery method is presented. (C) 1999 Elsevie
r Science B,V. All rights reserved.